The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Olsalazine-Based Metal–Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery
Abstract
The drug olsalazine (H4olz) was employed as a ligand to synthesize a new series of mesoporous metal-organic frameworks that are expanded analogues of the well-known M2(dobdc) materials (dobdc(4-) = 2,5-dioxido-1,4-benzenedicarboxylate; M-MOF-74). The M2(olz) frameworks (M = Mg, Fe, Co, Ni, and Zn) exhibit high surface areas with large hexagonal pore apertures that are approximately 27 Å in diameter. Variable temperature H2 adsorption isotherms revealed strong adsorption at the open metal sites, and in situ infrared spectroscopy experiments on Mg2(olz) and Ni2(olz) were used to determine site-specific H2 binding enthalpies. In addition to its capabilities for gas sorption, the highly biocompatible Mg2(olz) framework was also evaluated as a platform for the delivery of olsalazine and other encapsulated therapeutics. The Mg2(olz) material (86 wt % olsalazine) was shown to release the therapeutic linker through dissolution of the framework under simulated physiological conditions. Furthermore, Mg2(olz) was used to encapsulate phenethylamine (PEA), a model drug for a broad class of bioactive compounds. Under simulated physiological conditions, Mg2(olz)(PEA)2 disassembled to release PEA from the pores and olsalazine from the framework itself, demonstrating that multiple therapeutic components can be delivered together at different rates. The low toxicity, high surface areas, and coordinatively unsaturated metal sites make these M2(olz) materials promising for a range of potential applications, including drug delivery in the treatment of gastrointestinal diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885
Cited by
Hadjiivanov, K. I., Panayotov, D. A., Mihaylov, M. Y., Ivanova, E. Z., Chakarova, K. K., Andonova, S. M., & Drenchev, N. L. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00487 · Cited by 1,278
Kökçam-Demir, Ü., Goldman, A., Esrafili, L., Gharib, M., Morsali, A., Weingart, O., & Janiak, C. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00609e · Cited by 895
Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications
Lu, K., Aung, T., Guo, N., Weichselbaum, R., & Lin, W. (2018) · Advanced Materials · doi:10.1002/adma.201707634 · Cited by 692
Lan, G., Ni, K., Xu, Z., Veroneau, S. S., Song, Y., & Lin, W. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01072 · Cited by 662
Nanoparticles of Metal‐Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine
Simon‐Yarza, T., Mielcarek, A., Couvreur, P., & Serre, C. (2018) · Advanced Materials · doi:10.1002/adma.201707365 · Cited by 648
Lu, K., He, C., Guo, N., Chan, C., Ni, K., Lan, G., Tang, H., Pelizzari, C., Fu, Y.-X., Spiotto, M. T., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0203-4 · Cited by 596
Chiral Metal–Organic Frameworks
Gong, W., Chen, Z., Dong, J., Liu, Y., & Cui, Y. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00740 · Cited by 579
Metal-organic frameworks for advanced drug delivery
He, S., Wu, L., Li, X., Sun, H., Xiong, T., Liu, J., Huang, C., Xu, H., Sun, H., Chen, W., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.019 · Cited by 528
Nanoscale metal–organic frameworks for drug delivery: a conventional platform with new promise
Wang, L., Zheng, M., & Xie, Z. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb02970e · Cited by 505
Synthesis and modification of ZIF-8 and its application in drug delivery and tumor therapy
Wang, Q., Sun, Y., Li, S., Zhang, P., & Yao, Q. (2020) · RSC Advances · doi:10.1039/d0ra07950b · Cited by 399
Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy
Ni, K., Lan, G., Veroneau, S. S., Duan, X., Song, Y., & Lin, W. (2018) · Nature Communications · doi:10.1038/s41467-018-06655-7 · Cited by 329
Titanium-Based Nanoscale Metal–Organic Framework for Type I Photodynamic Therapy
Lan, G., Ni, K., Veroneau, S. S., Feng, X., Nash, G. T., Luo, T., Xu, Z., & Lin, W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13804 · Cited by 317
Wuttke, S., Lismont, M., Escudero, A., Rungtaweevoranit, B., & Parak, W. J. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.025 · Cited by 286
Metal-Organic Framework (MOF)-Based Drug Delivery
Cao, J., Li, X., & Tian, H. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618152518 · Cited by 282
Polysaccharide based metal organic frameworks (polysaccharide–MOF): A review
Nadar, S. S., Vaidya, L., Maurya, S., & Rathod, V. K. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.05.011 · Cited by 275
Multifunctional Efficiency: Extending the Concept of Atom Economy to Functional Nanomaterials
Freund, R., Lächelt, U., Gruber, T., Rühle, B., & Wuttke, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b00932 · Cited by 262
Metal-organic frameworks: A novel platform for combined advanced therapies
Rojas, S., Arenas-Vivo, A., & Horcajada, P. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.02.032 · Cited by 261
Endogenous Hydrogen Sulfide-Triggered MOF-Based Nanoenzyme for Synergic Cancer Therapy
Li, Y., Zhou, J., Wang, L., & Xie, Z. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c08659 · Cited by 125
Metadata
- Authors
- Levine, D. J., Runčevski, T., Kapelewski, M. T., Keitz, B. K., Oktawiec, J., Reed, D. A., Mason, J. A., Jiang, H. Z. H., Colwell, K. A., Legendre, C. M., FitzGerald, S. A., & Long, J. R.
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-08-03
- Volume
- 138
- Issue
- 32
- Pages
- 10143-10150
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2489650263
- Cited by
- 202
- References
- 1
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.